Signatur Biosciences has raised a total of $9.9 million through a mix of equity and grants.
Founders
Celestin de Wergifosse, Dr. John Goertz
Company Description
Signatur Biosciences is a precision diagnostics startup focused on transforming breast cancer care through affordable and accessible molecular tests. The company aims to decentralize diagnostic capabilities, enabling local hospitals to provide timely and personalized care.